Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORA22 (SNORA22) is a non-coding RNA gene that belongs to the H/ACA box class of snoRNAs. SNORA22 is predicted to guide the conversion of specific uridines to pseudouridine in ribosomal RNA, a post-transcriptional modification important for rRNA maturation and function. As a non-coding RNA, SNORA22 is not considered a conventional drug target (such as a receptor, enzyme, or transporter) and has no known clinical biomarkers, disease associations, or interacting drugs.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORA22 (SNORA22).